Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Influenzavirus B Infection Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Vectura Group Plc
Amarillo Biosciences Inc
Green Cross Corp
Aphios Corp
Mucosis BV
Inovio Pharmaceuticals Inc
Adimmune Corp
Sanofi
Novavax Inc
Sanofi Pasteur SA
ContraFect Corp
AbbVie Inc
Altravax Inc
SK Chemicals Co Ltd
Vaxart Inc
Romark Laboratories LC
Shionogi & Co Ltd
TSRL Inc
MedImmune LLC
Cadila Healthcare Ltd
Park Active Molecules
Kineta Inc
Medicago Inc
GlaxoSmithKline Plc
By Type:
APP-309
KIN-1400
CF-403
GC-3106A
Others
By Application:
Hospital
Others
Clinic
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Influenzavirus B Infection Drug Market Overview 2018-2029
-
1.1 China Influenzavirus B Infection Drug Industry Development Overview
-
1.2 China Influenzavirus B Infection Drug Industry Development History
-
1.3 China Influenzavirus B Infection Drug Industry Market Size (2018-2029)
-
1.4 China Influenzavirus B Infection Drug Market Analysis by Type from Production Side
-
1.4.1 China Influenzavirus B Infection Drug Production Volume, Production Value and Growth Rate of APP-309 (2018-2029)
-
1.4.2 China Influenzavirus B Infection Drug Production Volume, Production Value and Growth Rate of KIN-1400 (2018-2029)
-
1.4.3 China Influenzavirus B Infection Drug Production Volume, Production Value and Growth Rate of CF-403 (2018-2029)
-
1.4.4 China Influenzavirus B Infection Drug Production Volume, Production Value and Growth Rate of GC-3106A (2018-2029)
-
1.4.5 China Influenzavirus B Infection Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.5 China Influenzavirus B Infection Drug Market Analysis by Application from Consumption End
-
1.5.1 China Influenzavirus B Infection Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.5.2 China Influenzavirus B Infection Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.3 China Influenzavirus B Infection Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
1.6 China Influenzavirus B Infection Drug Market Analysis by Region
-
1.6.1 North China Influenzavirus B Infection Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Influenzavirus B Infection Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Influenzavirus B Infection Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Influenzavirus B Infection Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Influenzavirus B Infection Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Influenzavirus B Infection Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Influenzavirus B Infection Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Influenzavirus B Infection Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Influenzavirus B Infection Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Influenzavirus B Infection Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Influenzavirus B Infection Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Influenzavirus B Infection Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Influenzavirus B Infection Drug Industry Development
Chapter 3 Influenzavirus B Infection DrugIndustry Chain Analysis
-
3.1 Influenzavirus B Infection Drug Industry Chain
-
3.2 Influenzavirus B Infection Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Influenzavirus B Infection Drug Market
-
3.3 Influenzavirus B Infection Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Influenzavirus B Infection Drug Market
Chapter 4 China Influenzavirus B Infection Drug Market, by Type
-
4.1 China Influenzavirus B Infection Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Influenzavirus B Infection Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Influenzavirus B Infection Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Influenzavirus B Infection Drug Production Volume and Growth Rate of APP-309
-
4.5.2 China Influenzavirus B Infection Drug Production Volume and Growth Rate of KIN-1400
-
4.5.3 China Influenzavirus B Infection Drug Production Volume and Growth Rate of CF-403
-
4.5.4 China Influenzavirus B Infection Drug Production Volume and Growth Rate of GC-3106A
-
4.5.5 China Influenzavirus B Infection Drug Production Volume and Growth Rate of Others
Chapter 5 China Influenzavirus B Infection Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Influenzavirus B Infection Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Influenzavirus B Infection Drug Market Size and Growth Rate, by Application
-
5.5.1 China Influenzavirus B Infection Drug Market Size and Growth Rate of Hospital
-
5.5.2 China Influenzavirus B Infection Drug Market Size and Growth Rate of Others
-
5.5.3 China Influenzavirus B Infection Drug Market Size and Growth Rate of Clinic
Chapter 6 China Influenzavirus B Infection Drug Market, by Region
-
6.1 China Influenzavirus B Infection Drug Production Volume and Production Value, by Region
-
6.2 China Influenzavirus B Infection Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Influenzavirus B Infection Drug Market Analysis
-
7.1 North China Influenzavirus B Infection Drug Market, by Type
-
7.2 North China Influenzavirus B Infection Drug Market, by Application
Chapter 8 Central China Influenzavirus B Infection Drug Market Analysis
-
8.1 Central China Influenzavirus B Infection Drug Market, by Type
-
8.2 Central China Influenzavirus B Infection Drug Market, by Application
Chapter 9 South China Influenzavirus B Infection Drug Market Analysis
-
9.1 South China Influenzavirus B Infection Drug Market, by Type
-
9.2 South China Influenzavirus B Infection Drug Market, by Application
Chapter 10 East China Influenzavirus B Infection Drug Market Analysis
-
10.1 East China Influenzavirus B Infection Drug Market, by Type
-
10.2 East China Influenzavirus B Infection Drug Market, by Application
Chapter 11 Northeast China Influenzavirus B Infection Drug Market Analysis
-
11.1 Northeast China Influenzavirus B Infection Drug Market, by Type
-
11.2 Northeast China Influenzavirus B Infection Drug Market, by Application
Chapter 12 Southwest China Influenzavirus B Infection Drug Market Analysis
-
12.1 Southwest China Influenzavirus B Infection Drug Market, by Type
-
12.2 Southwest China Influenzavirus B Infection Drug Market, by Application
Chapter 13 Northwest China Influenzavirus B Infection Drug Market Analysis
-
13.1 Northwest China Influenzavirus B Infection Drug Market, by Type
-
13.2 Northwest China Influenzavirus B Infection Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Vectura Group Plc
-
14.1.1 Vectura Group Plc Company Profile
-
14.1.2 Vectura Group Plc Influenzavirus B Infection Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Amarillo Biosciences Inc
-
14.2.1 Amarillo Biosciences Inc Company Profile
-
14.2.2 Amarillo Biosciences Inc Influenzavirus B Infection Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Green Cross Corp
-
14.3.1 Green Cross Corp Company Profile
-
14.3.2 Green Cross Corp Influenzavirus B Infection Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Aphios Corp
-
14.4.1 Aphios Corp Company Profile
-
14.4.2 Aphios Corp Influenzavirus B Infection Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Mucosis BV
-
14.5.1 Mucosis BV Company Profile
-
14.5.2 Mucosis BV Influenzavirus B Infection Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Inovio Pharmaceuticals Inc
-
14.6.1 Inovio Pharmaceuticals Inc Company Profile
-
14.6.2 Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Adimmune Corp
-
14.7.1 Adimmune Corp Company Profile
-
14.7.2 Adimmune Corp Influenzavirus B Infection Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Sanofi
-
14.8.1 Sanofi Company Profile
-
14.8.2 Sanofi Influenzavirus B Infection Drug Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Novavax Inc
-
14.9.1 Novavax Inc Company Profile
-
14.9.2 Novavax Inc Influenzavirus B Infection Drug Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Sanofi Pasteur SA
-
14.10.1 Sanofi Pasteur SA Company Profile
-
14.10.2 Sanofi Pasteur SA Influenzavirus B Infection Drug Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 ContraFect Corp
-
14.11.1 ContraFect Corp Company Profile
-
14.11.2 ContraFect Corp Influenzavirus B Infection Drug Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 AbbVie Inc
-
14.12.1 AbbVie Inc Company Profile
-
14.12.2 AbbVie Inc Influenzavirus B Infection Drug Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Altravax Inc
-
14.13.1 Altravax Inc Company Profile
-
14.13.2 Altravax Inc Influenzavirus B Infection Drug Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 SK Chemicals Co Ltd
-
14.14.1 SK Chemicals Co Ltd Company Profile
-
14.14.2 SK Chemicals Co Ltd Influenzavirus B Infection Drug Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Vaxart Inc
-
14.15.1 Vaxart Inc Company Profile
-
14.15.2 Vaxart Inc Influenzavirus B Infection Drug Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Romark Laboratories LC
-
14.16.1 Romark Laboratories LC Company Profile
-
14.16.2 Romark Laboratories LC Influenzavirus B Infection Drug Market Performance
-
14.16.3 Product&Service Introduction
-
14.17 Shionogi & Co Ltd
-
14.17.1 Shionogi & Co Ltd Company Profile
-
14.17.2 Shionogi & Co Ltd Influenzavirus B Infection Drug Market Performance
-
14.17.3 Product&Service Introduction
-
14.18 TSRL Inc
-
14.18.1 TSRL Inc Company Profile
-
14.18.2 TSRL Inc Influenzavirus B Infection Drug Market Performance
-
14.18.3 Product&Service Introduction
-
14.19 MedImmune LLC
-
14.19.1 MedImmune LLC Company Profile
-
14.19.2 MedImmune LLC Influenzavirus B Infection Drug Market Performance
-
14.19.3 Product&Service Introduction
-
14.20 Cadila Healthcare Ltd
-
14.20.1 Cadila Healthcare Ltd Company Profile
-
14.20.2 Cadila Healthcare Ltd Influenzavirus B Infection Drug Market Performance
-
14.20.3 Product&Service Introduction
-
14.21 Park Active Molecules
-
14.21.1 Park Active Molecules Company Profile
-
14.21.2 Park Active Molecules Influenzavirus B Infection Drug Market Performance
-
14.21.3 Product&Service Introduction
-
14.22 Kineta Inc
-
14.22.1 Kineta Inc Company Profile
-
14.22.2 Kineta Inc Influenzavirus B Infection Drug Market Performance
-
14.22.3 Product&Service Introduction
-
14.23 Medicago Inc
-
14.23.1 Medicago Inc Company Profile
-
14.23.2 Medicago Inc Influenzavirus B Infection Drug Market Performance
-
14.23.3 Product&Service Introduction
-
14.24 GlaxoSmithKline Plc
-
14.24.1 GlaxoSmithKline Plc Company Profile
-
14.24.2 GlaxoSmithKline Plc Influenzavirus B Infection Drug Market Performance
-
14.24.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Influenzavirus B Infection Drug Industry Research Conclusions
-
15.2 Influenzavirus B Infection Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Influenzavirus B Infection Drug Industry Market Size (2018-2029)
-
Figure China Influenzavirus B Infection Drug Production Volume, Production Value and Growth Rate of APP-309 (2018-2029)
-
Figure China Influenzavirus B Infection Drug Production Volume, Production Value and Growth Rate of KIN-1400 (2018-2029)
-
Figure China Influenzavirus B Infection Drug Production Volume, Production Value and Growth Rate of CF-403 (2018-2029)
-
Figure China Influenzavirus B Infection Drug Production Volume, Production Value and Growth Rate of GC-3106A (2018-2029)
-
Figure China Influenzavirus B Infection Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Influenzavirus B Infection Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure China Influenzavirus B Infection Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Influenzavirus B Infection Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
Figure North China Influenzavirus B Infection Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Influenzavirus B Infection Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Influenzavirus B Infection Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Influenzavirus B Infection Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Influenzavirus B Infection Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Influenzavirus B Infection Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Influenzavirus B Infection Drug Market Size and Growth Rate from 2018-2029
-
Figure Influenzavirus B Infection Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Influenzavirus B Infection Drug Market Share by Type in 2018
-
Figure China Influenzavirus B Infection Drug Market Share by Type in 2023
-
Figure China Influenzavirus B Infection Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Influenzavirus B Infection Drug Production Volume and Growth Rate of APP-309 (2018-2023)
-
Figure China Influenzavirus B Infection Drug Production Volume and Growth Rate of KIN-1400 (2018-2023)
-
Figure China Influenzavirus B Infection Drug Production Volume and Growth Rate of CF-403 (2018-2023)
-
Figure China Influenzavirus B Infection Drug Production Volume and Growth Rate of GC-3106A (2018-2023)
-
Figure China Influenzavirus B Infection Drug Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Influenzavirus B Infection Drug Market Share by Application in 2018
-
Figure China Influenzavirus B Infection Drug Market Share by Application in 2023
-
Figure China Influenzavirus B Infection Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Influenzavirus B Infection Drug Market Size and Growth Rate of Hospital (2018-2023)
-
Figure China Influenzavirus B Infection Drug Market Size and Growth Rate of Others (2018-2023)
-
Figure China Influenzavirus B Infection Drug Market Size and Growth Rate of Clinic (2018-2023)
-
Table China Influenzavirus B Infection Drug Production Volume by Region (2018-2023)
-
Table China Influenzavirus B Infection Drug Production Volume Share by Region (2018-2023)
-
Figure China Influenzavirus B Infection Drug Production Volume Share by Region (2018-2023)
-
Table China Influenzavirus B Infection Drug Production Value by Region (2018-2023)
-
Table China Influenzavirus B Infection Drug Production Value Share by Region (2018-2023)
-
Figure China Influenzavirus B Infection Drug Production Value Share by Region (2018-2023)
-
Table China Influenzavirus B Infection Drug Sales Volume by Region (2018-2023)
-
Table China Influenzavirus B Infection Drug Sales Volume Share by Region (2018-2023)
-
Figure China Influenzavirus B Infection Drug Sales Volume Share by Region (2018-2023)
-
Table China Influenzavirus B Infection Drug Sales Value by Region (2018-2023)
-
Table China Influenzavirus B Infection Drug Sales Value Share by Region (2018-2023)
-
Figure China Influenzavirus B Infection Drug Sales Value Share by Region (2018-2023)
-
Table North China Influenzavirus B Infection Drug Production Volume by Type (2018-2023)
-
Table North China Influenzavirus B Infection Drug Production Volume Share by Type (2018-2023)
-
Figure North China Influenzavirus B Infection Drug Production Volume Share by Type (2018-2023)
-
Table North China Influenzavirus B Infection Drug Sales Volume by Application (2018-2023)
-
Table North China Influenzavirus B Infection Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Influenzavirus B Infection Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Influenzavirus B Infection Drug Production Volume by Type (2018-2023)
-
Table Central China Influenzavirus B Infection Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Influenzavirus B Infection Drug Production Volume Share by Type (2018-2023)
-
Table Central China Influenzavirus B Infection Drug Sales Volume by Application (2018-2023)
-
Table Central China Influenzavirus B Infection Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Influenzavirus B Infection Drug Sales Volume Share by Application (2018-2023)
-
Table South China Influenzavirus B Infection Drug Production Volume by Type (2018-2023)
-
Table South China Influenzavirus B Infection Drug Production Volume Share by Type (2018-2023)
-
Figure South China Influenzavirus B Infection Drug Production Volume Share by Type (2018-2023)
-
Table South China Influenzavirus B Infection Drug Sales Volume by Application (2018-2023)
-
Table South China Influenzavirus B Infection Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Influenzavirus B Infection Drug Sales Volume Share by Application (2018-2023)
-
Table East China Influenzavirus B Infection Drug Production Volume by Type (2018-2023)
-
Table East China Influenzavirus B Infection Drug Production Volume Share by Type (2018-2023)
-
Figure East China Influenzavirus B Infection Drug Production Volume Share by Type (2018-2023)
-
Table East China Influenzavirus B Infection Drug Sales Volume by Application (2018-2023)
-
Table East China Influenzavirus B Infection Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Influenzavirus B Infection Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Influenzavirus B Infection Drug Production Volume by Type (2018-2023)
-
Table Northeast China Influenzavirus B Infection Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Influenzavirus B Infection Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Influenzavirus B Infection Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Influenzavirus B Infection Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Influenzavirus B Infection Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Influenzavirus B Infection Drug Production Volume by Type (2018-2023)
-
Table Southwest China Influenzavirus B Infection Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Influenzavirus B Infection Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Influenzavirus B Infection Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Influenzavirus B Infection Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Influenzavirus B Infection Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Influenzavirus B Infection Drug Production Volume by Type (2018-2023)
-
Table Northwest China Influenzavirus B Infection Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Influenzavirus B Infection Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Influenzavirus B Infection Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Influenzavirus B Infection Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Influenzavirus B Infection Drug Sales Volume Share by Application (2018-2023)
-
Table Vectura Group Plc Company Profile
-
Table Vectura Group Plc Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table Amarillo Biosciences Inc Company Profile
-
Table Amarillo Biosciences Inc Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table Green Cross Corp Company Profile
-
Table Green Cross Corp Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table Aphios Corp Company Profile
-
Table Aphios Corp Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table Mucosis BV Company Profile
-
Table Mucosis BV Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table Inovio Pharmaceuticals Inc Company Profile
-
Table Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table Adimmune Corp Company Profile
-
Table Adimmune Corp Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table Novavax Inc Company Profile
-
Table Novavax Inc Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table Sanofi Pasteur SA Company Profile
-
Table Sanofi Pasteur SA Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table ContraFect Corp Company Profile
-
Table ContraFect Corp Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table AbbVie Inc Company Profile
-
Table AbbVie Inc Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table Altravax Inc Company Profile
-
Table Altravax Inc Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table SK Chemicals Co Ltd Company Profile
-
Table SK Chemicals Co Ltd Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table Vaxart Inc Company Profile
-
Table Vaxart Inc Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table Romark Laboratories LC Company Profile
-
Table Romark Laboratories LC Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table Shionogi & Co Ltd Company Profile
-
Table Shionogi & Co Ltd Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table TSRL Inc Company Profile
-
Table TSRL Inc Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table MedImmune LLC Company Profile
-
Table MedImmune LLC Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table Cadila Healthcare Ltd Company Profile
-
Table Cadila Healthcare Ltd Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table Park Active Molecules Company Profile
-
Table Park Active Molecules Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table Kineta Inc Company Profile
-
Table Kineta Inc Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table Medicago Inc Company Profile
-
Table Medicago Inc Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Plc Company Profile
-
Table GlaxoSmithKline Plc Influenzavirus B Infection Drug Revenue, Price and Gross (2018-2023)
-
